Clinical trial
A Randomized Double Blinded Placebo-Controlled Phase III Trial Comparing Cyclosporine Plus Steroids With or Without Myfortic as Primary Treatment for Extensive Chronic Graft Versus Host Disease
NCT00298324 is registered in ClinicalTrials.gov with European Society for Blood and Marrow Transplantation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Double Blinded Placebo-Controlled Phase III Trial Comparing Cyclosporine Plus Steroids With or Without Myfortic as Primary Treatment for Extensive Chronic Graft Versus Host Disease
- Lead sponsor
- European Society for Blood and Marrow Transplantation
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- September 30, 2006
- Completion date
- November 30, 2010
- Enrollment
- 34 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.